Saiyed Atiq Raza Sells 106,031 Shares of Arteris (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) Director Saiyed Atiq Raza sold 106,031 shares of Arteris stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $17.21, for a total value of $1,824,793.51. Following the completion of the sale, the director owned 393,690 shares in the company, valued at $6,775,404.90. This represents a 21.22% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Saiyed Atiq Raza also recently made the following trade(s):

  • On Wednesday, March 4th, Saiyed Atiq Raza sold 3,690 shares of Arteris stock. The stock was sold at an average price of $17.02, for a total value of $62,803.80.
  • On Friday, February 27th, Saiyed Atiq Raza sold 11,762 shares of Arteris stock. The shares were sold at an average price of $17.01, for a total value of $200,071.62.
  • On Thursday, February 26th, Saiyed Atiq Raza sold 73,610 shares of Arteris stock. The stock was sold at an average price of $17.14, for a total value of $1,261,675.40.
  • On Wednesday, February 25th, Saiyed Atiq Raza sold 4,907 shares of Arteris stock. The stock was sold at an average price of $17.00, for a total transaction of $83,419.00.

Arteris Stock Up 1.7%

Arteris stock traded up $0.28 during mid-day trading on Wednesday, hitting $16.46. The company had a trading volume of 539,469 shares, compared to its average volume of 492,893. Arteris, Inc. has a 1 year low of $5.46 and a 1 year high of $19.85. The stock has a market cap of $748.39 million, a price-to-earnings ratio of -20.07 and a beta of 1.45. The business has a fifty day moving average of $15.90 and a 200 day moving average of $13.81.

Arteris (NASDAQ:AIPGet Free Report) last announced its earnings results on Thursday, February 12th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The business had revenue of $20.14 million during the quarter, compared to analyst estimates of $18.55 million. Equities analysts anticipate that Arteris, Inc. will post -0.73 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages recently commented on AIP. Northland Securities set a $24.00 price target on shares of Arteris in a research report on Friday, February 13th. TD Cowen reissued a “buy” rating on shares of Arteris in a report on Wednesday, November 5th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Arteris in a research report on Wednesday, January 21st. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $20.00 price target on shares of Arteris in a research report on Friday, February 13th. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $20.17.

Read Our Latest Stock Report on AIP

Hedge Funds Weigh In On Arteris

Several hedge funds and other institutional investors have recently modified their holdings of AIP. Worth Venture Partners LLC bought a new position in Arteris in the 2nd quarter valued at $451,000. Franklin Resources Inc. grew its stake in shares of Arteris by 9.6% during the 2nd quarter. Franklin Resources Inc. now owns 1,637,171 shares of the company’s stock worth $15,602,000 after acquiring an additional 142,936 shares in the last quarter. Campbell & CO Investment Adviser LLC acquired a new position in Arteris during the second quarter valued at approximately $254,000. Squarepoint Ops LLC grew its position in shares of Arteris by 143.8% in the 2nd quarter. Squarepoint Ops LLC now owns 120,957 shares of the company’s stock valued at $1,153,000 after acquiring an additional 71,340 shares during the period. Finally, XTX Topco Ltd acquired a new stake in Arteris during the 2nd quarter valued at $405,000. Institutional investors own 64.36% of the company’s stock.

About Arteris

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

Featured Articles

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.